NEW YORK, October 12, 2017 /PRNewswire/ --
If you want a Stock Review on MBOT, COO, WAT, or BCR then come over tohttp://dailystocktracker.com/register/ and sign up for your free customized report. On Wednesday, the NASDAQ Composite ended the day at 6,603.55, up 0.25%; the Dow Jones Industrial Average edged 0.18% higher, to finish at 22,872.89; and the S&P
Yokneam, Israel-based Microbot Medical Inc.'s stock finished Wednesday's session 2.26% higher at $1.36 with a total trading volume of 1.33 million shares. The stock has gained 17.24% in the past month and 17.24% over the past three months. The Company's shares are trading above their 50-day moving average by 17.93%. Moreover, shares of Microbot Medical, which engages in the research, design, development, and commercialization of micro-robotics medical technologies, have a Relative Strength Index (RSI) of 58.82. MBOT complete research report is just a click away and free at:
The Cooper Cos.
Shares in Pleasanton, California headquartered The Cooper Cos. Inc. rose 1.52%, ending yesterday's session at $237.52 with a total trading volume of 356,454 shares. The stock has gained 32.23% over the past twelve months and 35.78% on an YTD basis. The Company's shares are trading above their 200-day moving average by 9.39%. Moreover, shares of Cooper Cos., which operates as a medical device company worldwide, have an RSI of 46.88.
On September 12th, 2017, research firm Stifel reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $265 a share to $275 a share. The complimentary report on COO can be downloaded at:
On Wednesday, Milford, Massachusetts-based Waters Corp.'s stock saw a rise of 0.36%, to close the day at $185.67. A total volume of 462,662 shares was traded. The Company's shares have advanced 18.39% over the last twelve months and 38.16% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 2.09% and 10.54%, respectively. Additionally, shares of Waters, which operates as an analytical instrument manufacturer in the US and internationally, have an RSI of 57.92.
On October 09th, 2017, research firm Cleveland Research downgraded the Company's stock rating from 'Buy' to 'Neutral'. Sign up for your complimentary research report on WAT at:
Shares in Murray Hill, New Jersey headquartered C.R. Bard Inc. ended the day 0.50% higher at $321.58. A total volume of 278,403 shares was traded. The stock has gained 47.68% over the last twelve months and 43.14% since the start of this year. The Company's shares are trading above their 50-day and 200-day moving averages by 0.51% and 12.51%, respectively. Furthermore, shares of C.R. Bard, which together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide, have an RSI of 55.24. Get free access to your research report on BCR at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Subscribe to our Free Newsletters!
Parkinson's disease (PD) is a chronic and progressive disease of the nervous system, causing ...
Iridectomy is a procedure in which an opening is made in the iris of the eye.
Hand hygiene is a simple and affordable technique to prevent infections.View All